Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

415 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW. Sollinger HW. Transplantation. 1995 Aug 15;60(3):225-32. doi: 10.1097/00007890-199508000-00003. Transplantation. 1995. PMID: 7645033 Clinical Trial.
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.
Salvadori M, Holzer H, Civati G, Sollinger H, Lien B, Tomlanovich S, Bertoni E, Seifu Y, Marrast AC; ERL B301 Study Group. Salvadori M, et al. Among authors: sollinger h. Clin Nephrol. 2006 Aug;66(2):112-9. Clin Nephrol. 2006. PMID: 16939067 Clinical Trial.
Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.
Kovarik JM, Pescovitz MD, Sollinger HW, Kaplan B, Legendre C, Salmela K, Book BK, Gerbeau C, Girault D, Somberg K; Simulect Phase IV Sudy group. Kovarik JM, et al. Among authors: sollinger hw. Clin Transplant. 2001 Apr;15(2):123-30. doi: 10.1034/j.1399-0012.2001.150208.x. Clin Transplant. 2001. PMID: 11264639 Clinical Trial.
From mice to man: the preclinical history of mycophenolate mofetil.
Sollinger HW. Sollinger HW. Clin Transplant. 1996 Feb;10(1 Pt 2):85-92. Clin Transplant. 1996. PMID: 8680054 Review.
Long-term pancreatic allograft survival after renal retransplantation in prior simultaneous pancreas-kidney recipients.
Lamattina J, Sollinger H, Becker Y, Mezrich J, Pirsch J, Odorico J. Lamattina J, et al. Among authors: sollinger h. Am J Transplant. 2012 Apr;12(4):937-46. doi: 10.1111/j.1600-6143.2011.03916.x. Epub 2012 Jan 10. Am J Transplant. 2012. PMID: 22233437
Response to Gaber.
Sollinger H, Neidlinger NA. Sollinger H, et al. Transplant Proc. 2010 Jun;42(5):1401. doi: 10.1016/j.transproceed.2010.04.020. Transplant Proc. 2010. PMID: 20620443 No abstract available.
Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing.
Cooper M, Salvadori M, Budde K, Oppenheimer F, Sollinger H, Zeier M. Cooper M, et al. Among authors: sollinger h. Transplant Rev (Orlando). 2012 Oct;26(4):233-40. doi: 10.1016/j.trre.2012.02.001. Epub 2012 Aug 3. Transplant Rev (Orlando). 2012. PMID: 22863029 Review.
Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
Pietruck F, Budde K, Salvadori M, Sollinger H, Bourbigot B, Gentil MA, Oppenheimer F. Pietruck F, et al. Among authors: sollinger h. Clin Transplant. 2007 Jan-Feb;21(1):117-25. doi: 10.1111/j.1399-0012.2006.00615.x. Clin Transplant. 2007. PMID: 17302600
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.
Salvadori M, Holzer H, de Mattos A, Sollinger H, Arns W, Oppenheimer F, Maca J, Hall M; ERL B301 Study Groups. Salvadori M, et al. Among authors: sollinger h. Am J Transplant. 2004 Feb;4(2):231-6. doi: 10.1046/j.1600-6143.2003.00337.x. Am J Transplant. 2004. PMID: 14974944 Clinical Trial.
Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study.
Lorber MI, Mulgaonkar S, Butt KM, Elkhammas E, Mendez R, Rajagopalan PR, Kahan B, Sollinger H, Li Y, Cretin N, Tedesco H; B251 Study Group. Lorber MI, et al. Among authors: sollinger h. Transplantation. 2005 Jul 27;80(2):244-52. doi: 10.1097/01.tp.0000164352.65613.24. Transplantation. 2005. PMID: 16041270 Clinical Trial.
415 results
Jump to page
Feedback